Built on Trust, Driven by Innovation A Conversation with Tyler WhiteSenior Director of Business Development, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. Tyler White, Senior Director of Business Development More than Meets the Eye If you picture a business development executive, you probably do not picture someone spending weekends caring for a…
NOW AVAILABLE on the APP Store and Google Play: The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs,…
On behalf of our CEO Eric Zudak, all of us at Thalocan Research Innovations congratulate everyone at AAD on the success of the 2026 Innovation Academy. So grateful for the conversations, the insights and learning about all of the new breakthroughs in dermatology. We’ll see you again, next year!
Innovation. That’s what we’re about, too. Tomorrow, Thalocan Research Innovations CEO Eric Zudak begins four days at AAD innovation Academy 2026 – packed with the latest breakthroughs in dermatology, cutting-edge clinical insights and meaningful networking moments. Here at TRI we share this mindset of creating and sharing innovative and state-of-the-art technologies to assist physicians, trialists…
